间歇性θ爆发式磁刺激治疗创伤后应激障碍
结果显示,2周时active iTBS显著改善社会与职业功能(Cohen's d=0.39),抑郁改善未达显著;1个月时active iTBS在临床与自评PTSD症状、抑郁及社会职业功能上均优于假刺激。
要点
- iTBS在退伍军人PTSD中耐受性良好,保留率高,盲法成功。
- 2周时社会职业功能显著改善,1个月时PTSD症状与功能均显著优于假刺激。
- 默认模式网络连接强度可预测临床改善。
核心结论
- iTBS似乎是PTSD有前景的新治疗,多数临床改善出现较早,需进一步研究最佳时程与持续时间。
主要发现
- 2周时active iTBS显著改善社会职业功能(d=0.39),抑郁改善未达显著(d=-0.45),自评PTSD症状中等非显著效应(d=-0.34)。
- 1个月时active iTBS在临床与自评PTSD症状(d=-0.74和-0.63)、抑郁(d=-0.47)及社会职业功能(d=0.93)均显著优于假刺激。
- 临床改善由默认模式网络内更强正连接及跨网络负连接显著预测。
关键数值与推荐
- iTBS剂量为1800脉冲/日,共10天假对照期加10次非盲治疗。
- 2周时社会职业功能效应量Cohen's d=0.39;1个月时PTSD症状d=-0.74和-0.63,抑郁d=-0.47,功能d=0.93。
临床怎么用
- iTBS可作为PTSD的潜在治疗选择,尤其关注社会职业功能与PTSD症状的早期及1个月改善。
- 默认模式网络连接特征可能辅助预测iTBS应答。
局限性
- 1个月结局纳入非盲阶段数据,可能影响效应估计。
- 样本为退伍军人,结果外推需谨慎。
- 部分结局(如2周抑郁)未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder associated with disruption in social and occupational function. Transcranial magnetic stimulation (TMS) represents a novel approach to PTSD, and intermittent theta-burst stimulation (iTBS) is a new, more rapid administration protocol with data supporting efficacy in depression. The authors conducted a sham-controlled study of iTBS for PTSD. METHODS: Fifty veterans with PTSD received 10 days of sham-controlled iTBS (1,800 pulses/day), followed by 10 unblinded sessions. Primary outcome measures included acceptability (retention rates), changes in PTSD symptoms (clinician- and self-rated), quality of life, social and occupational function, and depression, obtained at the end of 2 weeks; analysis of variance was used to compare active with sham stimulation. Secondary outcomes were evaluated 1 month after treatment, using mixed-model analyses. Resting-state functional MRI was acquired at pretreatment baseline on an eligible subset of participants (N=26) to identify response predictors. RESULTS: Retention was high, side effects were consistent with standard TMS, and blinding was successful. At 2 weeks, active iTBS was significantly associated with improved social and occupational function (Cohen's d=0.39); depression was improved with iTBS compared with the sham treatment (d=-0.45), but the difference fell short of significance, and moderate nonsignificant effect sizes were observed on self-reported PTSD symptoms (d=-0.34). One-month outcomes, which incorporated data from the unblinded phase of the study, indicated superiority of active iTBS on clinician- and self-rated PTSD symptoms (d=-0.74 and -0.63, respectively), depression (d=-0.47), and social and occupational function (d=0.93) (all significant). Neuroimaging indicated that clinical improvement was significantly predicted by stronger (greater positive) connectivity within the default mode network and by anticorrelated (greater negative) cross-network connectivity. CONCLUSIONS: iTBS appears to be a promising new treatment for PTSD. Most clinical improvements from stimulation occurred early, which suggests a need for further investigation of optimal iTBS time course and duration. Consistent with previous neuroimaging studies of TMS, default mode network connectivity played an important role in response prediction.
引用
- Philip NS, Barredo J, Aiken E, et al. Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder. Am J Psychiatry. 2019. PMID: 31230462. doi:10.1176/appi.ajp.2019.18101160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。